Disease & disorder
ovarian seromucinous carcinoma
MONDO:0004032
A malignant mixed epithelial neoplasm that arises from the ovary and is composed predominantly of serous and endocervical-type mucinous epithelium.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
1 shownDrugs being studied
Research locations
AtlantaGeorgia, United States1Beverly HillsCalifornia, United States1BillingsMontana, United States1Chapel HillNorth Carolina, United States1ChicagoIllinois, United States1ClevelandOhio, United States1ColumbusOhio, United States1DecaturIllinois, United States1DuarteCalifornia, United States1EdinaMinnesota, United States1HamiltonOntario, Canada1HartfordConnecticut, United States1
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.